JP2017516883A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516883A5
JP2017516883A5 JP2016561865A JP2016561865A JP2017516883A5 JP 2017516883 A5 JP2017516883 A5 JP 2017516883A5 JP 2016561865 A JP2016561865 A JP 2016561865A JP 2016561865 A JP2016561865 A JP 2016561865A JP 2017516883 A5 JP2017516883 A5 JP 2017516883A5
Authority
JP
Japan
Prior art keywords
cancer
disease
condition
composition according
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016561865A
Other languages
English (en)
Japanese (ja)
Other versions
JP6480467B2 (ja
JP2017516883A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/004480 external-priority patent/WO2015155810A1/en
Publication of JP2017516883A publication Critical patent/JP2017516883A/ja
Publication of JP2017516883A5 publication Critical patent/JP2017516883A5/ja
Application granted granted Critical
Publication of JP6480467B2 publication Critical patent/JP6480467B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016561865A 2014-04-07 2014-09-01 疎水性薬物送達のための新規なポリマーベースのヒドロトロープ Expired - Fee Related JP6480467B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461976354P 2014-04-07 2014-04-07
US61/976,354 2014-04-07
PCT/JP2014/004480 WO2015155810A1 (en) 2014-04-07 2014-09-01 Novel polymer-based hydrotropes for hydrophobic drug delivery

Publications (3)

Publication Number Publication Date
JP2017516883A JP2017516883A (ja) 2017-06-22
JP2017516883A5 true JP2017516883A5 (enExample) 2017-10-19
JP6480467B2 JP6480467B2 (ja) 2019-03-13

Family

ID=51535486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016561865A Expired - Fee Related JP6480467B2 (ja) 2014-04-07 2014-09-01 疎水性薬物送達のための新規なポリマーベースのヒドロトロープ

Country Status (10)

Country Link
US (1) US10080737B2 (enExample)
EP (1) EP3129425B1 (enExample)
JP (1) JP6480467B2 (enExample)
KR (1) KR102256453B1 (enExample)
CN (1) CN106133024B (enExample)
AU (1) AU2014390729B2 (enExample)
CA (1) CA2943733C (enExample)
RU (1) RU2676680C2 (enExample)
TW (1) TWI694838B (enExample)
WO (1) WO2015155810A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801847A (zh) * 2016-03-16 2016-07-27 华东师范大学 一种用于抗肿瘤药物递送的助溶高分子载体及制备方法
CN112402617B (zh) * 2020-11-20 2023-06-09 汕头大学 血影紫杉醇及其制备方法与应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US5811119A (en) 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
EP0775742A3 (en) 1989-09-29 1998-01-14 La Jolla Cancer Research Foundation Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix
US20040028682A1 (en) 1989-09-29 2004-02-12 Border Wayne A. Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix
US5234604A (en) 1991-02-26 1993-08-10 Betz Laboratories, Inc. Water soluble block copolymers and methods of use therof
AU670777B2 (en) 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
JPH08268906A (ja) 1995-03-31 1996-10-15 Sumitomo Pharmaceut Co Ltd 肺線維症予防剤
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
AU756301B2 (en) 1997-08-20 2003-01-09 Somagenics, Inc. Antisense and antigene therapeutics with improved binding properties and methods for their use
JPH11269076A (ja) 1998-01-22 1999-10-05 Seikagaku Kogyo Co Ltd 抗線維化剤
EP1177796B1 (en) 1999-04-27 2011-04-27 Mitsubishi Tanabe Pharma Corporation Medicament for prevention or therapeutic treatment of liver disease
US20020041898A1 (en) 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents
CA2402613A1 (en) 2000-03-29 2001-10-04 Igor Gonda Cationic liposomes
JP2002047211A (ja) 2000-08-04 2002-02-12 Japan Science & Technology Corp 脂溶性物質と生理活性高分子物質結合体および細胞核内への導入方法
US20030096739A1 (en) 2001-04-13 2003-05-22 Morris Patricia L. Nuclear receptor-mediated introduction of a PNA into cell nuclei
JP4547696B2 (ja) 2001-06-07 2010-09-22 第一三共株式会社 肝硬変予防・治療剤
JP2002371006A (ja) 2001-06-11 2002-12-26 Mochida Pharmaceut Co Ltd 肺線維症予防および/または進行防止剤
JP2003119138A (ja) 2001-10-09 2003-04-23 Tohoku Techno Arch Co Ltd 間質性肺炎および/または肺線維症の予防治療剤
CA2464346A1 (en) 2001-10-30 2003-05-08 Nektar Therapeutics Al, Corporation Water-soluble polymer conjugates of retinoic acid
ES2401326T3 (es) 2001-11-21 2013-04-18 Astellas Pharma Inc. Procedimiento para inhibir la expresión génica
JP3803318B2 (ja) 2001-11-21 2006-08-02 株式会社RNAi 遺伝子発現阻害方法
AU2002343094A1 (en) 2001-11-26 2003-06-10 Arachnova Therapeutics Ltd. Use of ppar activators for the treatment of pulmonary fibrosis
CA2484640C (en) 2002-05-15 2012-01-17 Endocyte, Inc. Vitamin-mitomycin conjugates
ATE488530T1 (de) 2002-06-19 2010-12-15 Raven Biotechnologies Inc Internalisierende antikörper spezifisch für das raag10 zelloberflächenziel
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
AU2003262811A1 (en) 2002-08-27 2004-03-19 Intermune, Inc. Methods of treating idiopathic pulmonary fibrosis
JP2006510586A (ja) 2002-08-29 2006-03-30 ユニバーシティー オブ サザンプトン 肝疾患治療のための薬剤の調製におけるアポトーシス誘導物質の使用方法
JP5576007B2 (ja) 2003-01-27 2014-08-20 エンドサイト・インコーポレイテッド ビタミン受容体結合性薬剤送達結合体
AU2004227414A1 (en) 2003-04-03 2004-10-21 Alnylam Pharmaceuticals iRNA conjugates
FR2855521B1 (fr) * 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
WO2005084702A1 (ja) 2004-03-02 2005-09-15 Hokkaido Technology Licensing Office Co., Ltd. 臓器線維症予防・治療剤
US20130171240A1 (en) 2004-12-22 2013-07-04 Nitto Denko Corporation Drug carrier and drug carrier kit for inhibiting fibrosis
AU2005320014B2 (en) 2004-12-22 2011-05-26 Nitto Denko Corporation Drug carrier and drug carrier kit for inhibiting fibrosis
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
JP2009221164A (ja) 2008-03-17 2009-10-01 Nitto Denko Corp 肺線維症処置剤
EP2077290B1 (en) * 2005-12-05 2010-04-21 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
GB0524987D0 (en) 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
JP5342834B2 (ja) 2008-09-05 2013-11-13 日東電工株式会社 骨髄線維症処置剤
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
US20130210744A1 (en) 2007-03-30 2013-08-15 Nitto Denko Corporation Targeting agent for cancer cell or cancer-associated fibroblast
TWI407971B (zh) 2007-03-30 2013-09-11 日東電工股份有限公司 Cancer cells and tumor-related fibroblasts
ES2430380T3 (es) * 2007-05-09 2013-11-20 Nitto Denko Corporation Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido
KR20100065190A (ko) 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
AU2008359989A1 (en) * 2008-07-30 2010-02-04 Nitto Denko Corporation Drug carriers
TW201630627A (zh) 2008-09-12 2016-09-01 日東電工股份有限公司 纖維化疾病之造影劑
JP5685267B2 (ja) 2009-12-09 2015-03-18 日東電工株式会社 Hsp47発現の調節
CN102933233A (zh) 2010-06-17 2013-02-13 日东电工株式会社 肾纤维化处理剂
JP5950428B2 (ja) 2010-08-05 2016-07-13 日東電工株式会社 線維化組織から正常組織を再生するための組成物
US20160015656A2 (en) 2010-08-05 2016-01-21 Nitto Denko Corporation Composition for regenerating normal tissue from fibrotic tissue
JP6023709B2 (ja) 2011-06-21 2016-11-09 日東電工株式会社 アポトーシス誘導剤
AU2012337691B2 (en) 2011-11-18 2017-10-12 Nitto Denko Corporation Intestinal fibrosis treatment agent
WO2013154707A1 (en) * 2012-04-12 2013-10-17 Nitto Denko Corporation Co-polymer conjugates

Similar Documents

Publication Publication Date Title
IL280941A (en) Modified double-stranded rna agents
JP2016028092A5 (enExample)
JP2016065085A5 (enExample)
JP2016535100A5 (enExample)
JP2016515522A5 (enExample)
JP2015503422A5 (enExample)
ZA201608108B (en) Huntington's disease therapeutic compounds
JP2016502162A5 (enExample)
JP2016523252A5 (enExample)
DK3463269T3 (da) Hånddesinfektionsmiddel
JP2016540026A5 (enExample)
JP2015173751A5 (enExample)
JP2017531686A5 (enExample)
JP2015016294A5 (enExample)
JP2016069874A5 (enExample)
JP2016011847A5 (enExample)
JP2015168758A5 (enExample)
LT3148588T (lt) N,n-bis-2-merkaptoetilizoftalamidas, skirtas parkinsono ligos gydymui
JP2016034310A5 (enExample)
JP2015000697A5 (enExample)
TH152083B (th) หน้าตัดโลหะ
TH152025B (th) รถแทร็กเตอร์
UA27523S (uk) Оздоблювальний бордюр «капсула»
CN302490243S (zh) 花洒
CN302562258S (zh) 蒸面器(nt520)